Updated Dec. 31, 2013 at 7:50 a.m.

Premium Lock Argos files for $60M IPO to finance cancer immunotherapy trial

Published: 2013-12-30 21:46:00
Updated: 2013-12-31 07:50:00

Argos' immunotherapy process Argos' immunotherapy process as explained in an animation at its website. Image 1 of 2 · Next Image…

Nearly two years after pulling back on IPO plans, Argos Therapeutics is again seeking to go public to finance phase III clinical trials for its kidney cancer immunotherapy. Read more about Argos' plans....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll